Vontobel Financial Products GmbH Stock

Certificat

DE000VM4YSV8

Market Closed - Deutsche Boerse AG 14:03:56 2024-06-28 EDT
96.6 EUR +0.31% Intraday chart for Vontobel Financial Products GmbH
Current month-1.95%
1 month-1.33%
Date Price Change
24-06-28 96.6 +0.31%
24-06-27 96.3 +0.26%
24-06-26 96.05 +0.29%
24-06-25 95.77 -0.55%
24-06-24 96.3 +0.67%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 02:03 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VM4YSV
ISINDE000VM4YSV8
Date issued 2023-11-20
Strike 161
Maturity 2024-09-20 (83 Days)
Parity 0.16 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 100
Lowest since issue 92.07

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
154.8 EUR
Average target price
184.4 EUR
Spread / Average Target
+19.18%
Consensus